Misalignment in Table and Typographical Errors in Text and Figure

In the Research Letter entitled “Specialty Drug Pricing and Out-of-Pocket Spending on Orally Administered Anticancer Drugs in Medicare Part D, 2010 to 2019,”¹ published in the May 28, 2019, issue of JAMA, a few columns were misaligned in the last 3 rows of the Table and pazopanib was misspelled in the Figure. Also, the first sentence of the second paragraph in the Results section should have read as follows: “Despite efforts to close the coverage gap between 2010 and 2019, mean expected out-of-pocket spending in 2019 benefit designs increased for 11 of 13 orally administered anticancer drugs available in both years…” This article was corrected online.